6 参考文献
1 Zhu JH, Tao QM, Chen JZ, et al. Statins contribute to enhancement of the number and the function of endothelial progenitor cells from peripheral blood. Sheng Li Xue Bao 2004 56:357-364
2 Kureishi Y, Luo Z, Shiojima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000;
1004-1010
3 Dulak J, Loboda A, Jazwa A, et al. Atorvastatin affects several angiogenic mediators in human endothelial cells. Endothelium 2005;233-241
4 周卿,陈书艳.他汀类药物对血管新生作用及机制的研究[J].国际心血管病杂志, 2006,33(1):45-48
5 Brouet A, Sonveaux P, Dessy C, et al.Hsp90 and caveolin are key targets for the proangiogenic nitric oxidemediated effects of statins.Circ Res 2001; 866-873
6 Frick M, Dulak J, Cisowski J, et al. Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells. Atherosclerosis 2003;229-236
7 Kusuyama T, Omura T, Nishiya D, et al. The effects of HMG-CoA reductase inhibitor on vascular progenitor cells. J Pharmacol Sci2006;101:344-349
8 Assmus B,Urbich C,Aicher A,et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res2003;92:1049-1055
9 Vasa M, Fichtlscherer S, Adler K. et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 2885-2890
10 Simons M. Molecular multitasking: statins lead to more arteries, less plaque. Nat Med 2000;6:965-966.
11 Bjerre LM,LeLorier J.Do statins cause cancer? A meta-analysis of large randomized clinical trials. Am J Med 2001;110: 716-723
12 Weis M,Heeschen C,Glassford AJ,et al.Statins have biphasic effects on angiogenesis. Circulation 2002; 105:739-745
13 Vincent L, Chen W, Hong L, et al.Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor:contribution to its anti-angiogenic effect. FEBS Lett 2001;495:
159-166
14 Sata M,Nishimatsu H,Osuga J,et al.Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis Hypertension 2004;43:1214-1220
15 Wassmann S. Werner N. Czech T. et al. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 2006;99: 74-83
16 Ozuyaman B, Ebner P, Niesler U et al.Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost 2005;94:770-772
17 Rauscher FM, Goldschmidt-Clermont PJ, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003;108: 457-463
18 George J, Afek A, Abashidze A et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice.
Arterioscler Thromb Vasc Biol 2005;25: 2636-2641
19 Silvestre JS, Gojova A, Brun V, et al. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque
composition. Circulation 2003;108: 2839-2842
20 Werner N, Kosiol S, Schiegl T, et al. Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl JMed 2005;353: 999-1007
21 OBrien KD, McDonald TM, Chait A et al. Neovascular expression ofE-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996;93: 672-682
22 George J, Afek A, Abashidze A et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice.
Arterioscler Thromb Vasc Biol 2005;25: 2636-2641
23 Kang HJ, Kim HS, Zhang SY et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-756
24 Kunz GA, Liang G, Cuculi F, et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J2006;152:190-195
25 Thum T, Fraccarollo D, Galuppo P, et al. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. Cardiovasc Res 2006;70 :50-60
26 王孟赞,孔祥泉.他汀类药物对血管内皮祖细胞的影响机制[J].中华老年心脑血管病杂志,2006,8(1):65-67
27 Werner N, Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 2006;10: 318-332
28 Aicher A, Heeschen C, Mildner-Rihm C,et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2006; 9:1370-1376
29 Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells.Circulation 2002; 105 : 3017-3024
30 陈玉国,徐峰,张运.内皮祖细胞与动脉粥样硬化蚀损斑块合并血栓形成[J].心血管病学进展,2006,27(1):1004-393

来源：中国组织工程研究与临床康复   作者：侯淑红，王挹青